의료 분야 전자 동의(eConsent) 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The eConsent In Healthcare Market size is expected to reach USD 1462.00 Million in 2034 from USD 582.77 Million (2025) growing at a CAGR of 10.76% during 2026-2034.

The global eConsent in healthcare market is growing rapidly as healthcare providers increasingly adopt digital solutions to streamline patient consent processes. eConsent platforms enable patients to review and sign consent forms electronically, improving efficiency and transparency in healthcare procedures. The growing digital transformation of healthcare systems is a major driver of market growth.

The increasing use of electronic health records and clinical research platforms is also encouraging the adoption of eConsent solutions. These systems help ensure regulatory compliance while improving patient engagement and understanding of medical procedures. Pharmaceutical companies and clinical research organizations are widely adopting eConsent technologies in clinical trials.

Looking forward, the market is expected to expand significantly as healthcare institutions continue to invest in digital health technologies. Advances in cloud computing, data security, and mobile healthcare platforms will further enhance eConsent solutions. The growing emphasis on patient-centered healthcare and regulatory compliance will continue to support market development.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Deployment Mode

• Cloud-Based
• On-Premises

By Application

• Clinical Trials
• Treatment Consent
• Telemedicine

By Workflow Integration

• Integrated Solutions
• Standalone Solutions

By User Interface

• Web-Based Platforms
• Mobile Applications

By End-Use

• Clinical Research Organizations
• Hospitals And Clinics
• Pharmaceutical And Biotech Companies
• Other End-Users

COMPANIES PROFILED

• Advarra, Calysta EM, Castor, Climedo Health GmbH, Clinical ink, Concentric Health Ltd, Epic Communications, EvidentIQ Group GmbH, Florence Healthcare, Interlace Health, IQVIA, Obvio Health USA Inc, Signant Health, Suvoda LLC, Veeva Systems
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ECONSENT IN HEALTHCARE MARKET: BY DEPLOYMENT MODE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Deployment Mode
• 4.2. Cloud-Based Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. On-Premises Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ECONSENT IN HEALTHCARE MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Clinical Trials Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Treatment Consent Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Telemedicine Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ECONSENT IN HEALTHCARE MARKET: BY WORKFLOW INTEGRATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Workflow Integration
• 6.2. Integrated Solutions Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Standalone Solutions Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ECONSENT IN HEALTHCARE MARKET: BY USER INTERFACE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast User Interface
• 7.2. Web-Based Platforms Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Mobile Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL ECONSENT IN HEALTHCARE MARKET: BY END-USE 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast End-use
• 8.2. Clinical Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Hospitals And Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Pharmaceutical And Biotech Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.5. Other End-Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL ECONSENT IN HEALTHCARE MARKET: BY REGION 2022-2034 (USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Deployment Mode
  • 9.2.2 By Application
  • 9.2.3 By Workflow Integration
  • 9.2.4 By User Interface
  • 9.2.5 By End-use
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Deployment Mode
  • 9.3.2 By Application
  • 9.3.3 By Workflow Integration
  • 9.3.4 By User Interface
  • 9.3.5 By End-use
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Deployment Mode
  • 9.4.2 By Application
  • 9.4.3 By Workflow Integration
  • 9.4.4 By User Interface
  • 9.4.5 By End-use
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Deployment Mode
  • 9.5.2 By Application
  • 9.5.3 By Workflow Integration
  • 9.5.4 By User Interface
  • 9.5.5 By End-use
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Deployment Mode
  • 9.6.2 By Application
  • 9.6.3 By Workflow Integration
  • 9.6.4 By User Interface
  • 9.6.5 By End-use
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL ECONSENT IN HEALTHCARE INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Advarra
  • 11.2.2 Calysta EM
  • 11.2.3 Castor
  • 11.2.4 Climedo Health GmbH
  • 11.2.5 Clinical Ink
  • 11.2.6 Concentric Health Ltd
  • 11.2.7 Epic Communications
  • 11.2.8 EvidentIQ Group GmbH
  • 11.2.9 Florence Healthcare
  • 11.2.10 Interlace Health
  • 11.2.11 IQVIA
  • 11.2.12 Obvio Health USA Inc
  • 11.2.13 Signant Health
  • 11.2.14 Suvoda LLC
  • 11.2.15 Veeva Systems